+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2014-07-08Number of Pages: 76

U.S. Antimicrobial Plastics Market for Electronic & Consumer Appliances, Personal Care, Packaging, Automotive, Building & Construction, Healthcare and Other Applications - Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020

Antimicrobial plastics are molded polymers infused with antimicrobials to inhibit the growth of various harmful microorganisms such as fungi and bacteria. Antimicrobial plastics are used in various industries such as healthcare, automotives, building & construction, electronics, packaging and consumer goods. Additionally, they are used in niche applications such as pipes, plastic water storage containers, waste bins and lids. Rising awareness among consumers regarding good health and cleanliness is expected to be one of the primary factors driving the growth of the antimicrobial plastics market. 

Antimicrobial plastics are increasingly used in packaging and electronic appliances as these products are highly susceptible to germs. This may result in transfer of infections. Additionally, growth in electronics, healthcare and packaging industries is anticipated to boost demand for antimicrobial plastics. Higher willingness of consumers to increase expenditure on products with antimicrobial properties is estimated to contribute significantly to the growth of the market.

The report on U.S.antimicrobial plastics market report forecasts and analyzes the antimicrobial plastics market on a regional level. The forecast demand on the global level is based on volume (tons) and revenue (USD million) for the period ranging from 2014 to 2020. The study on U.S. antimicrobial plastics market outlines drivers and restraints of the polyester market and their impact on market growth during the mentioned time period. Additionally, the study includes opportunities available for the market on the regional and level and their effect during the said forecast period.

All plastics infused with antimicrobials have been classified as antimicrobial plastics under the scope of this study. Personal care includes packaging of personal care products. Packaging of healthcare products has been classified under the packaging segment. Packaging typically includes foods, beverages and pharmaceuticals. In other words, the segment includes all types of packaging, except for personal care products.

We have conducted a detailed analysis of the value chain in order to help understand the antimicrobial plastics market better. Furthermore, Porter’s five forces model provides a better understanding of the intensity of competition in the market. The study comprises a market attractiveness analysis, wherein key applications are benchmarked based on their market size, growth rate and general attractiveness.

For the research report, we conducted in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents the bulk of research efforts, supplemented by an extensive secondary research. We reviewed key players’ product literature, annual reports, press releases and relevant documents for competitive analysis and market understanding. Secondary research also includes a search of recent trade, technical writing, internet sources, and statistical data from government websites, trade associations and agencies. This has proven to be the most reliable, effective and successful approach for obtaining precise market data, capturing industry participants’ insights and recognizing business opportunities. 

The report covers a detailed competitive outlook including the market share and company profiles of the key participants operating in the U.S. market. Key players profiled in the report include AkzoNobel N.V, BASF SE, Bayer AG, Bayer AG, E. I. du Pont de Nemours and Company, Lonza Group AG, Momentive Performance Materials Inc, Sinanen Zeomic Co Ltd, Sciessent LLC, Sherwin-Williams and Teknor Apex. Company profiles include attributes such as company overview, financial overview, business strategy, SWOT analysis and recent developments.

The study provides a decisive view of the antimicrobial plastics market by segmenting the market based on applications. All the applications have been analyzed based on present and future trends and the market is estimated from 2014 to 2020. The regional segmentation includes the current and forecast demand for U.S. This segmentation includes demand for individual applications in the particular region. For the purpose of this study, the antimicrobial plastics market has been segmented based on applications. Application segments have been analyzed and forecasted based on current trends at the regional level for the period between 2014 and 2020. The market has been segmented as below:

U.S. Antimicrobial Plastics Market – Application Segment Analysis
  • Electronics & consumer appliances
  • Personal care
  • Packaging
  • Automotive
  • Building & construction
  • Healthcare
  • Others (Includes sportswear, waste bins, etc.)


Chapter 1 Preface
1.1 Report description
1.2 Market segmentation
      1.2.1 U.S. antimicrobial plastics market segmentation
1.3 Research methodology
      1.3.1 Assumptions

Chapter 2 Executive Summary
2.1 U.S. antimicrobial plastics market, 2013 – 2020 (Tons) (USD Million)
2.2 U.S. antimicrobial plastics: Market snapshot (2013 and 2020)

Chapter 3 Antimicrobial Plastics – Industry Analysis
3.1 Introduction
3.2 Value chain analysis
3.3 Market drivers
      3.3.1 Growing demand for medical devices to augment market for antimicrobial plastics
              3.3.1.1 U.S. medical devices market, 2013 – 2020 (USD Billion)
      3.3.2 High rate of hospital-acquired infections to fuel demand for antimicrobial plastics
              3.3.2.1 U.S. hospital-acquired infection (HAIs) breakdown by types of infections, 2011 (%)
      3.3.3 Increasing demand for antimicrobial plastics in packaging
              3.3.3.1 U.S. plastic packaging market, 2013 – 2020 (USD Billion)
3.4 Market restraints
      3.4.1 Volatility in prices of raw materials to impact market growth
              3.4.1.1 Global silver prices, 2009 – 2014 (USD/kg)
3.5 Market opportunities
      3.5.1 Product innovation to open opportunities for market growth
3.6 U.S. regulatory scenario
3.7 Porter’s five forces analysis
      3.7.1 Bargaining power of suppliers
      3.7.2 Bargaining power of buyers
      3.7.3 Threat of new entrants
      3.7.4 Threat of substitutes
      3.7.5 Degree of competition
3.8 Market attractiveness analysis
3.9 Company market share analysis

Chapter 4 Antimicrobial Plastics Market – Application Analysis
4.1 U.S. antimicrobial plastics market: application overview
      4.1.1 U.S. antimicrobial plastics market volume share, by application, 2013 and 2020
4.2 U.S antimicrobial plastics market, by application
      4.2.1 Electronics & consumer appliances
              4.2.1.1 U.S. antimicrobial plastics market for electronics & consumer appliances, 2013 – 2020 (Tons) (USD Million)
      4.2.2 Personal care
              4.2.2.1 U.S antimicrobial plastics market for personal care, 2013 – 2020 (Tons) (USD Million)
      4.2.3 Packaging
              4.2.3.1 U.S. antimicrobial plastics market for packaging, 2013 – 2020 (Tons) (USD Million)
      4.2.4 Automotives
              4.2.4.1 U.S. antimicrobial plastics market for automotives, 2013 – 2020 (Tons) (USD Million)
      4.2.5 Building & construction
              4.2.5.1 U.S. antimicrobial plastics market for building & construction, 2013 – 2020 (Tons) (USD Million)
      4.2.6 Healthcare
              4.2.6.1 U.S. antimicrobial plastics market for healthcare, 2013 – 2020 (Tons) (USD Million)
      4.2.7 Others
              4.2.7.1 U.S. antimicrobial plastics market for other applications, 2013 – 2020 (Tons) (USD Million)

Chapter 5 Company Profiles
5.1 AkzoNobel N.V.
      5.1.1 Company overview
      5.1.2 Product portfolio
      5.1.3 Financial overview
      5.1.4 Business strategy
      5.1.5 SWOT analysis
      5.1.6 Recent developments
5.2 BASF SE
      5.2.1 Company overview
      5.2.2 Product portfolio
      5.2.3 Financial overview
      5.2.4 Business strategy
      5.2.5 SWOT analysis
      5.2.6 Recent developments
5.3 Bayer AG
      5.3.1 Company overview
      5.3.2 Product portfolio
      5.3.3 Financial overview
      5.3.4 Business strategy
      5.3.5 SWOT analysis
      5.3.6 Recent developments
5.4 Diamond Vogel
      5.4.1 Company overview
      5.4.2 Product portfolio
      5.4.3 Business strategy
      5.4.4 SWOT analysis
      5.4.5 Recent developments
5.5 E. I. du Pont de Nemours and Company
      5.5.1 Company overview
      5.5.2 Product portfolio
      5.5.3 Financial overview
      5.5.4 Business strategy
      5.5.5 SWOT analysis
      5.5.6 Recent developments
5.6 Ishizuka Glass Co. Ltd.
      5.6.1 Company overview
      5.6.2 Product portfolio
      5.6.3 Financial overview
      5.6.4 Business strategy
      5.6.5 SWOT analysis
      5.6.6 Recent developments
5.7 Lonza Group AG
      5.7.1 Company overview
      5.7.2 Product portfolio
      5.7.3 Financial overview
      5.7.4 Business strategy
      5.7.5 SWOT analysis
      5.7.6 Recent developments
5.8 Momentive Performance Materials Inc.
      5.8.1 Company overview
      5.8.2 Product portfolio
      5.8.3 Financial overview
      5.8.4 SWOT analysis
      5.8.5 Recent developments
5.9 Sinanen Zeomic Co Ltd
      5.9.1 Company overview
      5.9.2 Product portfolio
      5.9.3 Business strategy
      5.9.4 SWOT analysis
      5.9.5 Recent developments
5.10 Sciessent LLC
      5.10.1 Company overview
      5.10.2 Product portfolio
      5.10.3 Business strategy
      5.10.4 SWOT analysis
      5.10.5 Recent developments
5.11 Sherwin-Williams
      5.11.1 Company overview
      5.11.2 Product portfolio
      5.11.3 Financial overview
      5.11.4 Business strategy
      5.11.5 SWOT analysis
      5.11.6 Recent developments
5.12 Teknor Apex
      5.12.1 Company overview
      5.12.2 Product portfolio
      5.12.3 Business strategy
      5.12.4 SWOT analysis
5.13 The Dow Chemical Company
      5.13.1 Company overview
      5.13.2 Product portfolio
      5.13.3 Financial overview
      5.13.4 Business strategy
      5.13.5 SWOT analysis

List of Figures 

FIG. 1 U.S. antimicrobial plastics market segmentation
FIG. 2 U.S. antimicrobial plastics market, 2013 – 2020 (Tons) (USD Million)
FIG. 3 U.S. antimicrobial plastics market: Value chain analysis
FIG. 4 U.S. medical devices market, 2013 – 2020 (USD Billion)
FIG. 5 U.S. hospital acquired infection (HAIs) breakdown by types of infections, 2011 (%)
FIG. 6 U.S. plastic packaging market, 2013 – 2020 (USD Billion)
FIG. 7 Global silver prices, 2009 – 2014 (USD/kg)
FIG. 8 Porter’s five forces analysis
FIG. 9 U.S. antimicrobial plastics: Market attractiveness analysis
FIG. 10 U.S. antimicrobial plastics: Company market share analysis (2013)
FIG. 11 U.S. antimicrobial plastics market volume share, by application, 2013 and 2020
FIG. 12 U.S. antimicrobial plastics market for electronics & consumer appliances, 2013 -2020 (Tons) (USD Million)
FIG. 13 U.S. Antimicrobial Plastics Market for Personal Care, 2013 – 2020 (Tons) (USD Million)
FIG. 14 U.S. antimicrobial plastics for packaging, 2013 – 2020 (Tons) (USD Million)
FIG. 15 U.S. antimicrobial plastics for automotives, 2013 – 2020 (Tons) (USD Million)
FIG. 16 U.S. antimicrobial plastics for building & construction, 2013 – 2020 (Tons) (USD Million)
FIG. 17 U.S. antimicrobial plastics for healthcare, 2013 – 2020 (Tons) (USD Million)
FIG. 18 U.S. antimicrobial plastics for other applications, 2013 – 2020 (Tons) (USD Million)

List of Tables

TABLE 1 Antimicrobial plastics: U.S. snapshot
TABLE 2 Drivers for antimicrobial plastics market: Impact analysis
TABLE 3 Restraints for antimicrobial plastics market: Impact analysis

Antimicrobial plastics are a class of polymers that inhibit the growth of microorganisms such as bacteria, fungi and protozoans. These plastics are engineered by inserting or attaching active antimicrobial agents onto a polymer backbone. Antimicrobial plastics prevent bacterial growth in various products, thereby enhancing the quality and shelf life of products. Additionally, they help prevent illnesses and curtail infection by resisting bacterial growth. Furthermore, these plastics are employed in water sanitation applications to inhibit the growth of microorganisms in drinking water. 

The market for antimicrobial plastics has grown rapidly over the past few years. This trend is likely to continue in the near future. Research is being conducted to discover a new variety of plastic compounds in order to develop implants and biomedical devices with higher resistance to microbial adhesion and biofilm formation. A number of polymers have been developed that can be incorporated into cellulose and other materials. This would result in significant advances in various industries such as textiles, catheter tubes, food packaging, wound dressing and sterile surfaces. A greater need for materials that fight infection would act as an incentive for the discovery and usage of antimicrobial polymers.

Healthcare was the largest segment, accounting for about 44% of the total U.S. antimicrobial plastics industry in 2013. This was followed by packaging and electronic & consumer appliances segments. This trend is anticipated to continue during the forecast period. The usage of antimicrobial plastics in healthcare applications helps prevent and control infection. Demand for antimicrobial plastics in the U.S. is estimated to increase significantly due to the implementation of stringent regulations regarding healthcare and hygiene. Furthermore, personal care packaging, including skin care and hair care products and cosmetics, coupled with packaging of pharmaceuticals and food & beverages is projected to boost demand for antimicrobial plastics during the forecast period.

Demand for antimicrobial plastics stood at 100,062.1 tons in the U.S. in 2013 and is likely to rise significantly over the next six years. Factors such as increasing number of healthcare regulations, rising awareness regarding hospital-acquired infections, packaging of food & beverages, pharmaceuticals, medical devices, maintenance of automotives and usage in building & construction products are expected to boost the antimicrobial plastics market in the U.S. Antimicrobial plastics are governed by the Environmental Protection Agency (EPA) of the U.S. According to the EPA, plastics containing antimicrobials qualify as “treated articles.” Furthermore, antimicrobials are considered “pesticides” under the EPA. Due to this, antimicrobial plastics need to be registered with the EPA. There are several legislations in relation to antimicrobial plastics in medical devices. Most medical devices are governed by the EPA. However, antimicrobials that are intended to be released by the medical device are regulated by the FDA and classified as drugs.

The healthcare sector is subject to extensive regulation in the U.S. This is anticipated to fuel the demand for antimicrobial plastics in medical applications. Thus, the healthcare application segment in the country is estimated to grow significantly during the forecast period. Rising demand for antimicrobial plastics in personal care packaging segment in order to help maximize the shelf life and increase aesthetic appeal of products is projected to drive demand for antimicrobial plastics in the U.S. Pharmaceuticals are stored in containers made of antimicrobial plastics in order to preserve their quality and protect them from microbial attack. Thus, rising consumer awareness regarding hygiene and increasing number of deaths due to hospital-acquired infections is likely to boost demand for antimicrobial plastics in the market.

Key players in the U.S. antimicrobial plastics market include AkzoNobel, BASF, Bayer, the Dow Chemical Company, Lonza Group and Sherwin-Williams. The U.S. antimicrobial plastic market is fragmented in nature, with the top three companies accounting for over 35% of the market share in 2013. The antimicrobial plastics market can be segmented into companies manufacturing antimicrobials for plastics and companies producing antimicrobial infused plastics.

us-antimicrobial-plastics-market


A complete brochure for this research is available for download.

Interact with our pool of experienced analysts for any report related queries